Trial · NCT02004652
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to defaecation, measured in hours, from the time the surgery ends till the first observed passage of stool | up to 30 days after surgery | |
| Secondary | Time of first passing flatus reported by the patients(hours) | up to 30 days after surgery | |
| Secondary | Time to resume solid diet or total enteral nutrition(TEN)(days) | up to 30 days after surgery | |
| Secondary | Length of postoperative hospital stay (LOS)(days) | participants will be followed for the duration of postoperative hospital stay, an expected average of 8 days | |
| Secondary | Overall post-operative complication rate defined according to the Clavien-Dindo Classification | up to 30 days after surgery | |
| Secondary | Overall cost (RMB) | participants will be followed for the duration of postoperative hospital stay, an expected average of 8 days | |
| Secondary | Pain scores on visual analogue scale (from 0 which implies no pain at all, to 10 which implies the worst pain imaginable) on the first 3 postoperative days and postoperative analgesic requirement (number of doses on 50-mg Pethidine) | up to postoperative day 3 | |
| Secondary | Time to walk independently(days) | up to 30 days after surgery | |
| Secondary | Hospital Readmission Rates Post 30-day Discharge | up to 30 days after discharge | |
| Secondary | Length of postoperative ICU stay (days) | up to 30 days after surgery | |
| Secondary | Incidence of adverse events related to drug usage | up to 7 days after drug usage | Diarrhoea,Flatulence,Nausea,Abdominal pain,Headaches,Menstrual disorder,Dizziness ,Skeletal pain,ECG nodal arrhythmia |
| Secondary | Reinsertion of nasogastric tube | up to 30 days after surgery | |
| Other | Whole blood white blood cell(WBC) count on postoperative day 1 and 3 | postoperative day 1 and 3 | whole blood white blood cell (WBC) count(\*109/L) |
| Other | Whole blood neutrophil percentage on postoperative day 1 and 3 | postoperative day 1 and 3 | neutrophil percentage(%) |
| Other | Whole blood platelet level on postoperative day 1 and 3 | postoperative day 1 and 3 | platelet level(\*109/L) |
| Other | Serum C-reactive protein(CRP) level on postoperative day 1 and 3. | postoperative day 1 and 3 | CRP level(mg/dL) |
| Other | Serum interleukin-6(IL-6) level on postoperative day 1 and 3. | postoperative day 1 and 3 | IL-6(pg/ml) |
| Other | Serum procalcitonin(PCT) level on postoperative day 1 and 3. | postoperative day 1 and 3 | PCT(ug/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02004652/registered